He has dedicated the award to all of his low-grade serous cancer patients and families.
Unprecedented response rate in neoadjuvent trial for low-grade serous cancer
A Phase 2 study of 15 women with low-grade serous … Read More
Latest updates in low grade serous ovarian cancer treatment and research
“I’m pleased that we are living in times where progress … Read More
Dr Banerjee gives update on Phase 1/2 Frame trial for RAF/MEK/FAK inhibitor
Dr Susana Banerjee recently presented the updated results of the … Read More
Is chemotherapy necessary in newly diagnosed low-grade serous cancer?
One of the difficulties with low-grade serous ovarian cancer is … Read More
